GlobeNewswire: Vilacto Bio, Inc. Contains the last 10 of 21 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T23:33:48ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2019/04/09/1799769/0/en/Vilacto-Bio-offering-natural-alternatives-to-strong-drugs-in-the-Psoriasis-and-diabetics-market.html?f=22&fvtc=4&fvtv=35740Vilacto Bio offering natural alternatives to strong drugs in the Psoriasis and diabetics market2019-04-09T13:00:00Z<![CDATA[NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- Denmark-based Vilacto Bio Inc. (OTC QB: VIBI) is happy to announce that the company has decided to introduce 2 new products and present them for the market later this summer/fall. The company will present one product for people with psoriasis and one product for people suffering from diabetes, especially skin issues related to diabetes.]]>https://www.globenewswire.com/news-release/2019/03/15/1755289/0/en/Vilacto-Bio-Canada-Patent-LACTOACTIVE-Granted.html?f=22&fvtc=4&fvtv=35740Vilacto Bio Canada Patent LACTOACTIVE® Granted2019-03-15T13:00:00Z<![CDATA[NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Denmark-based Vilacto Bio Inc. (OTC QB:VIBI) is happy to announce that the Canadian Intellectual Property Office (CIPO) has informed the Company that its patent application for LACTOACTIVE® will be issued in near future.]]>https://www.globenewswire.com/news-release/2018/11/30/1660031/0/en/Vilacto-Bio-Secured-Patent-Applications-for-LACTOACTIVE.html?f=22&fvtc=4&fvtv=35740Vilacto Bio Secured Patent Applications for LACTOACTIVE®2018-11-30T13:30:00Z<![CDATA[NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- New York-based Vilacto Bio Inc. (OTC QB:VIBI) has secured the patent applications for LACTOACTIVE® covering rights in the US, Canada Europe and Hong Kong. The transaction was finalized this November.]]>https://www.globenewswire.com/news-release/2018/10/01/1587765/0/en/Vilacto-Bio-Announces-Launch-of-Carmen-Electra-by-Vilact.html?f=22&fvtc=4&fvtv=35740Vilacto Bio Announces Launch of Carmen Electra by Vilact®2018-10-01T12:30:00Z<![CDATA[COPENHAGEN, Denmark, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI) has launched its new skincare product, Carmen Electra by Vilact, based on the company’s LACTOACTIVE® compound.]]>https://www.globenewswire.com/news-release/2018/09/21/1574294/0/en/Vilacto-Bio-Unveils-Development-Programs-for-LACTOACTIVE-iTHER.html?f=22&fvtc=4&fvtv=35740Vilacto Bio Unveils Development Programs for LACTOACTIVE iTHER® 2018-09-21T12:30:00Z<![CDATA[COPENHAGEN, Denmark, Sept. 21, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI) has revealed the initial five areas of development for its new LACTOACTIVE iTHER® compound.]]>https://www.globenewswire.com/news-release/2018/09/10/1568816/0/en/Vilacto-Bio-Introduces-New-LACTOACTIVE-iTHER-Compound.html?f=22&fvtc=4&fvtv=35740Vilacto Bio Introduces New LACTOACTIVE iTHER® Compound2018-09-10T19:50:00Z<![CDATA[COPENHAGEN, Denmark, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI) has launched its LACTOACTIVE iTHER® product.]]>https://www.globenewswire.com/news-release/2018/07/11/1535924/0/en/Vilacto-Bio-Focuses-Resources-On-Pharmaceutical-Opportunities-for-LACTOACTIVE-iTHER.html?f=22&fvtc=4&fvtv=35740Vilacto Bio Focuses Resources On Pharmaceutical Opportunities for LACTOACTIVE iTHER® 2018-07-11T12:30:00Z<![CDATA[COPENHAGEN, Denmark, July 11, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTCQB:VIBI) plans to focus on its new pharmaceutical product, LACTOACTIVE iTHER®, as another potential revenue stream for the company along with its Vilact® brand of skin creams.]]>https://www.globenewswire.com/news-release/2018/06/14/1524611/0/en/Vilacto-Bio-s-Vilact-Skin-Cream-Wins-Award-at-Las-Vegas-ECRM-Skin-Bath-Cosmetics-Natural-Beauty-EPPS.html?f=22&fvtc=4&fvtv=35740Vilacto Bio’s Vilact Skin Cream Wins Award at Las Vegas ECRM Skin, Bath, Cosmetics & Natural Beauty EPPS2018-06-14T12:30:00Z<![CDATA[COPENHAGEN, Denmark, June 14, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc.’s (OTCQB:VIBI) Vilact skin cream won the buyers choice award at the recent ECRM Skin, Bath, Cosmetics & Natural Beauty EPPS (efficient program planning session) in Las Vegas, Nevada, USA.]]>https://www.globenewswire.com/news-release/2018/05/23/1510792/0/en/Vilacto-Bio-Inc-Upgrades-Denmark-Plant-Paves-Way-for-New-LACTOACTIVE-iTHER-to-Stimulate-Local-Antibody-Production.html?f=22&fvtc=4&fvtv=35740Vilacto Bio Inc. Upgrades Denmark Plant; Paves Way for New LACTOACTIVE iTHER® to Stimulate Local Antibody Production2018-05-23T12:30:00Z<![CDATA[COPENHAGEN, Denmark, May 23, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI) has completed a two-month upgrade to the Denmark production facility, which is owned by Pharma GP, that produces its patented LACTOACTIVE nanoparticle compound. This upgrade will enable the company to manufacture even smaller LACTOACTIVE particles and enable Vilacto Bio to start production of its new LACTOACTIVE iTHER®.]]>https://www.globenewswire.com/news-release/2018/01/18/1296382/0/en/Vilacto-Bio-Inc-Begins-Development-of-the-Vilacto-Bio-Skincare-Knowledge-Center.html?f=22&fvtc=4&fvtv=35740Vilacto Bio Inc. Begins Development of the Vilacto Bio Skincare Knowledge Center2018-01-18T13:30:00Z<![CDATA[COPENHAGEN, Denmark, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTCQB:VIBI), today announced that it has commenced development of the Vilacto Bio Skincare Knowledge Center, an online resource that will gather skincare knowledge, science, insights and tips from scientists, dermatologists, podiatrists and other specialists around the world. Skin challenges often stem from issues existing deeper in the layers of the tissue, not on the surface, minimizing the impact of traditional skin creams. The tips and guides presented in the Vilacto Bio Knowledge Center will be shared with industry magazines globally, as well as with Vilacto customers. The Vilacto Bio Knowledge Center is expected to enhance dialogue among specialists and consumers, improve outcomes and drive higher traffic to Vilacto’s commercial website.]]>